BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10594039)

  • 21. Mice lacking cyclin-dependent kinase inhibitor p19Ink4d show strain-specific effects on male reproduction.
    Buchold GM; Magyar PL; O'Brien DA
    Mol Reprod Dev; 2007 Aug; 74(8):1008-20. PubMed ID: 17393423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
    Guan KL; Jenkins CW; Li Y; O'Keefe CL; Noh S; Wu X; Zariwala M; Matera AG; Xiong Y
    Mol Biol Cell; 1996 Jan; 7(1):57-70. PubMed ID: 8741839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
    Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
    Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Pinto A; Demetrick DJ; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2000 Sep; 29(1):63-9. PubMed ID: 10918395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases.
    Zindy F; Cunningham JJ; Sherr CJ; Jogal S; Smeyne RJ; Roussel MF
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13462-7. PubMed ID: 10557343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
    Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
    Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subventricular zone.
    Coskun V; Luskin MB
    J Neurosci; 2001 May; 21(9):3092-103. PubMed ID: 11312294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
    Shiohara M; Spirin K; Said JW; Gombart AF; Nakamaki T; Takeuchi S; Hatta Y; Morosetti R; Tasaka T; Seriu T; Bartram C; Miller CW; Tomonaga M; Koeffler HP
    Leukemia; 1996 Dec; 10(12):1897-900. PubMed ID: 8946928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
    Kawamata N; Miller CW; Koeffler HP
    Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
    Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
    IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
    Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
    Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The INK4 family of CDK inhibitors.
    Carnero A; Hannon GJ
    Curr Top Microbiol Immunol; 1998; 227():43-55. PubMed ID: 9479825
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit.
    Cunningham JJ; Levine EM; Zindy F; Goloubeva O; Roussel MF; Smeyne RJ
    Mol Cell Neurosci; 2002 Mar; 19(3):359-74. PubMed ID: 11906209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
    Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
    J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.